Enhanced EHR-workflow-integrated communications enable prescribers to act on lower-cost therapeutic alternatives, while reinforcing Scripta’s proven member-driven savings model
BOSTON, Feb. 10, 2026 /PRNewswire/ — Scripta Insights, the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans, and their members to prescription savings, has strengthened its provider engagement capabilities through enhanced, secure EHR-workflow-integrated electronic fax communications.
The enhancement enables prescribing clinicians to review clinically equivalent, lower-cost alternatives and approve or decline recommended switches directly within their existing clinical workflows—supporting efficient alignment on potential savings opportunities, while preserving the physician’s clinical judgment and the member experience.
Unlike point solutions that focus on prescriber outreach alone, Scripta’s provider engagement capabilities operate as part of its broader Rx Navigation platform—connecting prescribers, members and plan sponsors through a single, clinically governed system designed to drive both immediate and sustained pharmacy savings.
When a savings opportunity is identified, Scripta delivers recommendations aligned to the employer’s benefit design and formulary directly to the provider, including pricing and therapeutic alternatives. Providers can then approve or decline the recommendation on the member’s behalf, reducing friction for patients and helping avoid prescription abandonment.
Scripta’s provider engagement model is governed by its independent Pharmacy & Therapeutics (P&T) Committee, composed of 30 actively practicing physicians and pharmacists representing 22 clinical specialties. The committee evaluates therapeutic alternatives based on clinical appropriateness, evidence and real-world practice considerations to ensure that recommendations reflect decisions a practicing clinician would reasonably make for their own patients.
This clinical governance model enables:
“At the end of a long day in the exam room, the last thing a physician wants is a message that simply says ‘change to this medication’ without context,” said Dr. Paul Bradley, Co-Founder and Chief Medical Officer of Scripta Insights. “Scripta’s enhanced provider engagement approach delivers the right information to clinicians at the right time, helping physicians have more informed, productive conversations with their patients—without disrupting how they already practice medicine.”
“Expanding clinically governed provider engagement scales a powerful lever we already use to help plan sponsors drive prescription savings,” said Eric Levin, CEO of Scripta Insights. “Across more than 100 employer and health plan clients, we see the strongest and most durable results when prescribers and members are both supported with clear, personalized guidance. Our Rx Navigation platform brings these capabilities together in a single, end-to-end solution that works within existing benefit designs and vendor ecosystems to help organizations drive meaningful and sustainable pharmacy savings.”
Across its client base, Scripta data shows:
Scripta’s Rx Navigation platform supports coordinated decision-making across members, prescribers and plan sponsors through tools including member-facing navigation, prescriber engagement, plan sponsor analytics and targeted incentive programs—working alongside any PBM and within a client’s existing benefit design.
Scripta operates as an independent, unbiased third party, delivering clinically governed recommendations, flexible integration and transparent reporting—designed to support plan sponsors in meeting their ERISA fiduciary responsibilities and aligned exclusively to employer and health plan goals.
About Scripta Insights
Scripta Insights is a venture-backed digital health company providing clinically governed pharmacy navigation solutions for self-insured employers, health plans and their members. Founded in 2019, the company’s platform was developed by physicians, pharmacists and data scientists to help stakeholders navigate the growing complexity of prescription benefits and medication decision-making.
For more information, visit www.scriptainsights.com and follow the company on LinkedIn.
Media Contact
Linda Krebs
LKPR, Inc. for Scripta Insights
lk@lkprinc.com
646-824-5186
View original content to download multimedia:https://www.prnewswire.com/news-releases/scripta-insights-expands-clinically-governed-provider-engagement-within-its-rx-navigation-platform-302683042.html
SOURCE Scripta Insights

Lawmakers in the US House of Representatives and Senate met with cryptocurrency industry leaders in three separate roundtable events this week. Members of the US Congress met with key figures in the cryptocurrency industry to discuss issues and potential laws related to the establishment of a strategic Bitcoin reserve and a market structure.On Tuesday, a group of lawmakers that included Alaska Representative Nick Begich and Ohio Senator Bernie Moreno met with Strategy co-founder Michael Saylor and others in a roundtable event regarding the BITCOIN Act, a bill to establish a strategic Bitcoin (BTC) reserve. The discussion was hosted by the advocacy organization Digital Chamber and its affiliates, the Digital Power Network and Bitcoin Treasury Council.“Legislators and the executives at yesterday’s roundtable agree, there is a need [for] a Strategic Bitcoin Reserve law to ensure its longevity for America’s financial future,” Hailey Miller, director of government affairs and public policy at Digital Power Network, told Cointelegraph. “Most attendees are looking for next steps, which may mean including the SBR within the broader policy frameworks already advancing.“Read more

